HRT Female (Initial)
Test Overview
The Hormone Replacement Therapy (HRT) Female Initial Panel is a comprehensive diagnostic test designed to assess key hormone levels in women before starting hormone therapy (HT). This test evaluates baseline hormonal balance, helping identify deficiencies or imbalances that may affect overall well-being, including symptoms related to menopause, perimenopause, or other hormonal disorders. By measuring estrogen, progesterone, testosterone, and other essential markers, this panel ensures a safe and personalized approach to HRT.
Test Types
- Comprehensive Hormone Panel – Measures key hormones to assess eligibility for HRT.
- Estrogen & Progesterone Panel – Evaluates hormonal balance for menopause management.
- Testosterone Panel – Assesses androgen levels in women.
- Thyroid Function Panel – Ensures proper thyroid function, which influences hormone metabolism.
- Lipid Panel & Metabolic Tests – Evaluates cardiovascular and metabolic health before therapy.
HRT Female (Initial) Test Results & Ranges
| Test Component: | Normal Range: | Abnormal (Indicates Hormonal Imbalance): |
|---|---|---|
| Estradiol (E2) | 15–350 pg/mL (premenopausal) <10 pg/mL (postmenopausal) | Low suggests estrogen deficiency |
| Progesterone | 0.1–0.3 ng/mL (follicular phase) 5–20 ng/mL (luteal phase) | Low may indicate luteal phase deficiency |
| Testosterone (Total) | 15–70 ng/dL | High may indicate androgen excess (e.g., PCOS) |
| Free Testosterone | 0.1–6.4 pg/mL | Elevated levels may cause symptoms like hair loss or acne |
| Luteinizing Hormone (LH) | 5–25 mIU/mL (varies by cycle) | High may indicate menopause or ovarian failure |
| Follicle-Stimulating Hormone (FSH) | 3–21 mIU/mL (premenopausal) >30 mIU/mL (postmenopausal) | High suggests menopause or ovarian dysfunction |
| DHEA-Sulfate (DHEA-S) | 35–430 µg/dL | Low suggests adrenal insufficiency |
| Sex Hormone-Binding Globulin (SHBG) | 18–144 nmol/L | Low may affect free hormone availability |
| Thyroid-Stimulating Hormone (TSH) | 0.4–4.0 µIU/mL | High or low suggests thyroid dysfunction |
| Prolactin | 4–23 ng/mL | Elevated may affect ovulation and hormone balance |
| Comprehensive Metabolic Panel (CMP) | Normal liver/kidney function | Abnormal may indicate metabolic concerns |
| Lipid Panel (Cholesterol, HDL, LDL, Triglycerides) | Within normal lipid guidelines | Abnormal may indicate cardiovascular risk |
Expected Turnaround Time
- Comprehensive Hormone Panel: 24–48 hours
- Thyroid & Metabolic Tests: 24–72 hours
Specimen Requirements
- Sample Type: Blood sample (venipuncture)
- Fasting Required? Recommended for lipid and metabolic tests
- Container: Serum separator tube (SST) or EDTA tube
Collection Instructions
- Fast for at least 8–12 hours if undergoing lipid or metabolic testing.
- Schedule blood draw based on menstrual cycle (if applicable):
- Follicular phase (Days 2–4): Best for FSH, LH, estradiol.
- Luteal phase (Days 19–21): Best for progesterone.
- Provide a full medication/supplement list before testing.
- Storage: Keep refrigerated if not processed immediately.
Test Details
- Clinical Use: Determines baseline hormone levels before starting HRT. Identifies hormonal imbalances related to menopause, perimenopause, or other conditions. Helps guide customized HRT plans for symptom relief and overall well-being.
- Limitations: Hormone levels fluctuate throughout the menstrual cycle; timing is crucial. Medications, stress, and lifestyle factors can affect results.
The HRT Female Initial Test provides a comprehensive hormone profile to ensure safe, effective, and personalized hormone replacement therapy.